Skip to main content
Watch Insiders
XERS filings

Corporate insider profile

Beth Hecht Filing Activity

Latest reported as See Remarks of Xeris Biopharma Holdings, Inc. (XERS).

Purchase filings
0
Reported companies
1
Net open-market value
-$204,787.43
Latest transaction
Jun 1, 2026

Affiliated corporations

Reported company relationships

XERSLatest reported

Xeris Biopharma Holdings, Inc.

See Remarks

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 1, 2026Xeris Biopharma Holdings, Inc. (XERS)See RemarksSale16,667$6.06$100,982
May 1, 2026Xeris Biopharma Holdings, Inc. (XERS)See RemarksSale16,667$6.23$103,805